Development of the simulation-based German albuminuria screening model (S-GASM) for estimating the cost-effectiveness of albuminuria screening in Germany
<h4>Background</h4> Chronic kidney disease is often asymptomatic in its early stages but constitutes a severe burden for patients and causes major healthcare systems costs worldwide. While models for assessing the cost-effectiveness of screening were proposed in the past, they often pres...
Main Authors: | Paul Kairys, Thomas Frese, Paul Voigt, Johannes Horn, Matthias Girndt, Rafael Mikolajczyk |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8730388/?tool=EBI |
Similar Items
-
Screening for risk with albuminuria: should we start from here?
by: Haynes, R, et al.
Published: (2010) -
Effect of MAFLD on albuminuria and the interaction between MAFLD and diabetes on albuminuria
by: Yufang Liu, et al.
Published: (2024-02-01) -
Determination of Albuminuria as a Component of Screening for Type 2 Diabetes Mellitus
by: L.O. Prystupiuk
Published: (2015-03-01) -
Albuminuria Screening in People With Type 2 Diabetes in a Managed Care Organization
by: Farrah Keong, MPH, et al.
Published: (2023-12-01) -
The pathogenesis of albuminuria in cadmium nephropathy
by: Soisungwan Satarug, et al.
Published: (2024-01-01)